不同痴呆风险因素与非洲裔美国人认知障碍及衰退速度的关联
研究在佛罗里达州杰克逊维尔梅奥诊所阿尔茨海默病研究中心完成至少2次随访的社区居住非洲裔美国人(AA;n=261)和非西班牙裔白人(nHW;n=193)中,评估可改变痴呆风险因素与认知障碍及衰退的关联。结果显示高血压、高胆固醇血症、肥胖和糖尿病在AA中更常见但与认知障碍无关;抑郁与AA(OR=4.30)和nHW(OR=2.79)认知障碍风险升高相关,且在AA中独与更快衰退相关(β=1.71)。
要点
- 抑郁与AA和nHW认知障碍风险升高相关,OR分别为4.30和2.79。
- 抑郁在AA中独与更快认知衰退相关(β=1.71)。
- AA中抗抑郁药使用比例低于nHW(18% vs 73%)。
核心结论
- 可改变痴呆风险因素在AA和nHW中常见,是重要的风险干预目标。
- 抑郁与AA和nHW的痴呆相关,并与AA认知功能加速衰退相关。
- 优化抑郁筛查和治疗可能改善AA的认知轨迹和结局。
研究设计与样本
- 社区居住的AA(n=261)和nHW(n=193)参与者在梅奥诊所阿尔茨海默病研究中心完成至少2次随访。
- 比较可改变痴呆风险因素及其与认知障碍(全局临床痴呆评定量表[CDR]≥0.5)和衰退速度(CDR Sum of Boxes)的关联。
- 分析控制人口学特征、APOE ɛ4状态和区域剥夺指数。
主要发现
- 高血压、高胆固醇血症、肥胖和糖尿病在AA中更常见,但与认知障碍无关。
- 抑郁与AA认知障碍风险升高相关(OR=4.30,95%CI=2.13-8.67),与nHW认知障碍风险升高相关(OR=2.79,95%CI=1.21-6.44)。
- 抑郁在AA中独与更快衰退相关(β=1.71,95%CI=0.69-2.73,p=0.001)。
- AA中报告抗抑郁药使用较少(9/49,18%),nHW为(57/78,73%,p<0.001)。
- 维生素B12缺乏与AA认知衰退速率增加相关(β=2.65,95%CI=0.38-4.91,p=0.023)。
临床怎么用
- 作者认为优化抑郁筛查和治疗可能改善AA的认知轨迹和结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was undertaken to evaluate the frequency of modifiable dementia risk factors and their association with cognitive impairment and rate of decline in diverse participants engaged in studies of memory and aging. METHODS: Modifiable dementia risk factors and their associations with cognitive impairment and cognitive decline were determined in community-dwelling African American (AA; n = 261) and non-Hispanic White (nHW; n = 193) participants who completed ≥2 visits at the Mayo Clinic Alzheimer Disease Research Center in Jacksonville, Florida. Risk factors and their associations with cognitive impairment (global Clinical Dementia Rating [CDR] ≥ 0.5) and rates of decline (CDR Sum of Boxes) in impaired participants were compared in AA and nHW participants, controlling for demographics, APOE ɛ4 status, and Area Deprivation Index. RESULTS: Hypertension, hypercholesterolemia, obesity, and diabetes were overrepresented in AA participants, but were not associated with cognitive impairment. Depression was associated with increased odds of cognitive impairment in AA (odds ratio [OR] = 4.30, 95% confidence interval [CI] = 2.13-8.67) and nHW participants (OR = 2.79, 95% CI = 1.21-6.44) but uniquely associated with faster decline in AA participants (β = 1.71, 95% CI = 0.69-2.73, p = 0.001). Fewer AA participants reported antidepressant use (9/49, 18%) than nHW counterparts (57/78, 73%, p < 0.001). Vitamin B12 deficiency was also associated with an increased rate of cognitive decline in AA participants (β = 2.65, 95% CI = 0.38-4.91, p = 0.023). INTERPRETATION: Modifiable dementia risk factors are common in AA and nHW participants, representing important risk mitigation targets. Depression was associated with dementia in AA and nHW participants, and with accelerated declines in cognitive function in AA participants. Optimizing depression screening and treatment may improve cognitive trajectories and outcomes in AA participants. ANN NEUROL 2024;95:518-529.
引用
- Lachner C, Craver EC, Babulal GM, et al. Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans. Ann Neurol. 2024. PMID: 38069571. doi:10.1002/ana.26847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。